Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).

MLA

Hernandez, Adrian F., et al. “Rationale and Design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).” American Heart Journal, vol. 157, no. 2, Feb. 2009, pp. 271–77. EBSCOhost, https://doi.org/10.1016/j.ahj.2008.07.031.

APA

Hernandez, A. F., O’Connor, C. M., Starling, R. C., Reist, C. J., Armstrong, P. W., Dickstein, K., Lorenz, T. J., Gibler, W. B., Hasselblad, V., Komajda, M., Massie, B., McMurray, J. J. V., Nieminen, M., Rouleau, J. L., Swedberg, K., & Califf, R. M. (2009). Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF). American Heart Journal, 157(2), 271–277. https://doi.org/10.1016/j.ahj.2008.07.031

Chicago

Hernandez, Adrian F., Christopher M. O’Connor, Randall C. Starling, Craig J. Reist, Paul W. Armstrong, Kenneth Dickstein, Todd J. Lorenz, et al. 2009. “Rationale and Design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).” American Heart Journal 157 (2): 271–77. doi:10.1016/j.ahj.2008.07.031.